For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
Localities prototypes pose puzzle - minutes give glimpse of new agencies’ thoughts on reform
+News
In print
Localities prototypes pose puzzle - minutes give glimpse of new agencies’ thoughts on reform
Wednesday 16 February 2022, 02:27 PM

Health and Disability Review Transition Unit director Stephen McKernan notes the risk to the health reform programme if appropriate people and capability are not able to be transferred in a timely way
Martin Johnston takes a look through the minutes of the early meetings of the new health agencies
It would be critical to ensure the appropriate management and governance structures are established as soon as possible
The new health authoritie
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.